$BNR News

Burning Rock Reports Second Quarter 2026 Financial Results

Burning Rock Biotech Q2 EPS $(0.20) Down From $(0.10) YoY, Sales $19.862M Down From $20.737M YoY

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Biotech Founding Chairman And CEO Mr. Yusheng Han Buys 73,141 BNR ADSs On Open Market For ~$618.2K

Burning Rock Reports First Quarter 2026 Financial Results

Burning Rock Biotech Q1 EPS $(0.20), Same YoY, Sales $15.649M Down From $18.340M YoY

Burning Rock Publishes 2025 Annual Report on Form 20-F

Burning Rock Announces Founder’s Purchase of Its ADSs

Brenntag Q4 Earnings Call Highlights

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

Burning Rock Biotech Q4 EPS $(0.20) Up From $(1.10) YoY, Sales $18.063M Up From $17.265M YoY

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Biotech Chairman And CEO Yusheng Han Acquires US$811,721 In Company ADSs Through Open Market Transactions

Burning Rock Biotech Chairman And CEO Yusheng Han Acquires US$811,721 In Company ADSs Through Open Market Transactions

Burning Rock Announces Results of 2025 Annual General Meeting

Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025

This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs

Burning Rock Reports Third Quarter 2025 Financial Results

Burning Rock Biotech Q3 EPS $(0.20) Up From $(0.50) YoY, Sales $18.488M Up From $18.331M YoY

Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer